1. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary. Issue 1 (30th November 2022) Authors: Posner, Atara; Prall, Owen WJ; Sivakumaran, Tharani; Etemadamoghadam, Dariush; Thio, Niko; Pattison, Andrew; Balachander, Shiva; Fisher, Krista; Webb, Samantha; Wood, Colin; DeFazio, Anna; Wilcken, Nicholas; Gao, Bo; Karapetis, Christos S; Singh, Madhu; Collins, Ian M; Richardson, Gary; Steer, Ch... Journal: Journal of pathology Issue: Volume 259:Issue 1(2023) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. Issue 4 (April 2016) Authors: Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, S... Journal: Lancet oncology Issue: Volume 17:Issue 4(2016:Apr.) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study. Issue 4 (April 2023) Authors: Solomon, Benjamin J; Bauer, Todd M; Mok, Tony S K; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; López, Froylán López; Soo, Ross A; Shaw, Alice T; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriq... Journal: Lancet Issue: Volume 11:Issue 4(2023) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial. Issue 12 (December 2019) Authors: Shaw, Alice T; Solomon, Benjamin J; Chiari, Rita; Riely, Gregory J; Besse, Benjamin; Soo, Ross A; Kao, Steven; Lin, Chia-Chi; Bauer, Todd M; Clancy, Jill S; Thurm, Holger; Martini, Jean-Francois; Peltz, Gerson; Abbattista, Antonello; Li, Sherry; Ou, Sai-Hong Ignatius Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Issue 12 (December 2017) Authors: Shaw, Alice T; Felip, Enriqueta; Bauer, Todd M; Besse, Benjamin; Navarro, Alejandro; Postel-Vinay, Sophie; Gainor, Justin F; Johnson, Melissa; Dietrich, Jorg; James, Leonard P; Clancy, Jill S; Chen, Joseph; Martini, Jean-François; Abbattista, Antonello; Solomon, Benjamin J Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. Issue 12 (December 2018) Authors: Solomon, Benjamin J; Besse, Benjamin; Bauer, Todd M; Felip, Enriqueta; Soo, Ross A; Camidge, D Ross; Chiari, Rita; Bearz, Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M; Riely, Gregory J; Tan, Eng Huat; Seto, Takashi; James, Leonard P; Clancy, Jill S; Abbattista, Antonello; Martini, Jean-François;... Journal: Lancet oncology Issue: Volume 19:Issue 12(2018) Page Start: 1654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lung cancer. Issue 10299 (7th August 2021) Authors: Thai, Alesha A; Solomon, Benjamin J; Sequist, Lecia V; Gainor, Justin F; Heist, Rebecca S Journal: Lancet Issue: Volume 398:Issue 10299(2021) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial. Issue 10378 (4th March 2023) Authors: de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen,... Journal: Lancet Issue: Volume 401:Issue 10378(2023) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗